SARS-CoV-2 secondary structure shapes mutation frequencies, constraining viral evolution models predicting fitness can benefit from integrating secondary structure data.
Monoclonal antibodies like etesevimab have lost efficacy against Omicron subvariants, necessitating innovative solutions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback